Home
Publish
Inicio
Publicar
Join Engormix and be part of the largest agribusiness social network in the world.
Login Register
Statistics:
(2197)
XXI World Veterinary Poultry Association Congress (WVPAC 2019)
menu
XXI World Veterinary Poultry Association Congress (WVPAC 2019)

XXI World Veterinary Poultry Association Congress (WVPAC 2019)

September 16, 2019 to September 20, 2019
BITEC Bangkok - Thailand
Lectures
14:45hs
9/17/2019
Bhiraj Hall 2-3
Marek’s disease: virus evolution vs vaccine development
Speaker:
John Dunn
John Dunn
United States
14:45hs
9/17/2019
Bhiraj Hall 2-3
15:45hs
9/17/2019
Nile Room 1-2
ILT vaccination induced seroconversion level in Dutch layer and breeder flocks
Speaker:
Jeanine Wiegel
Jeanine Wiegel
Netherlands
15:45hs
9/17/2019
Nile Room 1-2
15:45hs
9/17/2019
Silk Room 2-4
Serological response of white and brown pullets for Egg drop syndrome (EDS) virus and Avian rhinotracheitis (ART) virus after injection with 2 different inactivated vaccines in the Netherlands
Speaker:
Melchior de Bruin
Melchior de Bruin
15:45hs
9/17/2019
Silk Room 2-4
15:57hs
9/17/2019
Silk Room 2-4
Live vaccination with apathogenic Fowl Adenovirus serotype-1 protects layers from development of adenoviral gizzard erosion
Speaker:
Beatrice Grafl
Beatrice Grafl
Austria
15:57hs
9/17/2019
Silk Room 2-4
16:21hs
9/17/2019
Silk Room 2-4
Protection by a novel HVT-ND-IBD and two live attenuated vaccines against a variant E strain of Infectious bursal disease
Speaker:
Ivan Alvarado
Ivan Alvarado
Estados Unidos de América
DVM, MS, Ph.D, ACPV Diplomate Director, U.S. Technical Services & Life Cycle Management
16:21hs
9/17/2019
Silk Room 2-4
16:33hs
9/17/2019
Silk Room 2-4
Field safety and efficacy trials of NOVAMUNE® a new immune-complex IBD vaccine for layers
Speaker:
Zoltan Penzes
Zoltan Penzes
Hungary
Research
16:33hs
9/17/2019
Silk Room 2-4
16:45hs
9/17/2019
Silk Room 2-4
Comparison study of the efficacy of four commercial Infectious bursal disease vaccines against very virulent Infectious bursal disease virus challenge
Speaker:
Nataya Charoenvisal
Nataya Charoenvisal
Thailand
16:45hs
9/17/2019
Silk Room 2-4
16:57hs
9/17/2019
Nile Room 1-2
Commercial Broiler Performance Results From Broilers Vaccinated In Ovo With A Dual HVT Construct (HVT-ND-IBD) Vaccine
Speaker:
Sue Hubbard
Sue Hubbard
United States
16:57hs
9/17/2019
Nile Room 1-2
16:57hs
9/17/2019
Silk Room 2-4
Experimental and field results of antibody responses to immune-complex Infectious bursal disease virus vaccine in commercial broilers in Myanmar
Speaker:
Ye Htut Aung
Ye Htut Aung
Myanmar (Burma)
16:57hs
9/17/2019
Silk Room 2-4
16:57hs
9/17/2019
Nile Room 3-4
Methods to assess Infectious Laryngotracheitis vaccine take in broiler chickens
Speaker:
Awol Mohammed Assen
Awol Mohammed Assen
Ethiopia
16:57hs
9/17/2019
Nile Room 3-4
14:42hs
9/18/2019
Amber Room 1-3
Field experiences with a new gel-applied live coccidiosis vaccine in commercial “no antibiotics ever” broilers raised in the USA
Speaker:
Matilde Alfonso
Matilde Alfonso
14:42hs
9/18/2019
Amber Room 1-3
14:42hs
9/18/2019
Nile Room 1-2
Genome editing of Avian herpesviruses for studying viral pathogenesis and developing recombinant vaccines
Speaker:
Yongxiu Yao
Yongxiu Yao
14:42hs
9/18/2019
Nile Room 1-2
14:54hs
9/18/2019
Amber Room 1-3
A retrospective study on treatment interventions after coccidiosis vaccination with attenuated vaccines
Speaker:
Monita Vereecken
Monita Vereecken
Belgium
Technical Manager
14:54hs
9/18/2019
Amber Room 1-3
14:54hs
9/18/2019
Nile Room 1-2
HVT-ND and Rispens vaccines detection in chickens: Is there any statistical correlation among age, sample type, and vaccine strain?
Speaker:
Christophe Cazaban
Christophe Cazaban
France
14:54hs
9/18/2019
Nile Room 1-2
15:06hs
9/18/2019
Amber Room 1-3
HVT construct vaccine verification & monitoring of field virus challenge using viral FLEX-SEQ
Speaker:
Elise Myers
Elise Myers
Canada
15:06hs
9/18/2019
Amber Room 1-3
15:48hs
9/18/2019
Amber Room 1-3
Co-application of Mass-type and 793B-type vaccines provides high level of protection against Asian QX-like and Taiwanese variant IBV challenge
Speaker:
Tímea Tatár-Kis
Tímea Tatár-Kis
15:48hs
9/18/2019
Amber Room 1-3
16:00hs
9/18/2019
Bhiraj Hall 2-3
Protective immunity induced by Embryonated egg grown vaccine against Chlamydia psittaci experimentally in chickens
Speaker:
Eman Ragab Mohammed
Eman Ragab Mohammed
16:00hs
9/18/2019
Bhiraj Hall 2-3
16:12hs
9/18/2019
Amber Room 1-3
Evolution of Infectious bronchitis virus genomes in vaccinated and unvaccinated specific pathogen free chickens: a novel bioinformatic tool for visualizing variants
Speaker:
Alexandre Flageul
Alexandre Flageul
16:12hs
9/18/2019
Amber Room 1-3
16:36hs
9/18/2019
Bhiraj Hall 2-3
Assessment of the protective effect of different vaccination schemes against avian colibacillosis in commercial layer pullets after experimental intratracheal challenge
Speaker:
Dimitrios Koutsianos
Dimitrios Koutsianos
16:36hs
9/18/2019
Bhiraj Hall 2-3
16:36hs
9/18/2019
Amber Room 1-3
Is Infectious bronchitis virus reacting to widespread vaccine administration? Evidences from a large-scale Italian field study
Speaker:
Giovanni Franzo
Giovanni Franzo
Italy
16:36hs
9/18/2019
Amber Room 1-3
16:48hs
9/18/2019
Silk Room 1-2
Effect of Infectious bursal disease hatchery vaccines on H5 Avian Influenza vaccination immunity in commercial broilers
Speaker:
Ramy Alazzouny
Ramy Alazzouny
16:48hs
9/18/2019
Silk Room 1-2
16:48hs
9/18/2019
Bhiraj Hall 2-3
Natural antibody levels predict geneticallydetermined livability after intratracheal pathogenic Escherichia coli inoculation in chickens
Speaker:
Matthijs (Mieke)
Matthijs (Mieke)
Netherlands
assitant professor, researcher at Universiteit Utrecht
16:48hs
9/18/2019
Bhiraj Hall 2-3
16:48hs
9/18/2019
Amber Room 1-3
Simultaneous vaccination of multiple live attenuated respiratory viruses in day-old chicks: The impact on health and production
Speaker:
Dr Kannan Ganapathy
Dr Kannan Ganapathy
United Kingdom
Lecturer in infectious diseases
16:48hs
9/18/2019
Amber Room 1-3
17:00hs
9/18/2019
Silk Room 1-2
Effect of two distinct technology vaccines against Gumboro disease on lymphoid tissue of bursa of Fabricius
Speaker:
Lucas Pedroso Colvero
Lucas Pedroso Colvero
17:00hs
9/18/2019
Silk Room 1-2
17:00hs
9/18/2019
Bhiraj Hall 2-3
Preparation and evaluation of inactivated Pasteurella multocida vaccine in chicken
Speaker:
Wafaa Abd El-Ghany Abd El-Ghany
Wafaa Abd El-Ghany Abd El-Ghany
17:00hs
9/18/2019
Bhiraj Hall 2-3
15:30hs
9/19/2019
Silk Room 2-4
Protective efficacy of a Newcastle disease virus genotype VII-matched vaccine in commercial layers
Speaker:
Hesham Abd-Elrahman Sultan
Hesham Abd-Elrahman Sultan
15:30hs
9/19/2019
Silk Room 2-4
15:42hs
9/19/2019
Silk Room 2-4
Comparison of onset of protection induced by three recombinant HVT-NDV vaccines
Speaker:
Vich Satrakulwong
Vich Satrakulwong
15:42hs
9/19/2019
Silk Room 2-4
15:54hs
9/19/2019
Silk Room 2-4
Development of an inactivated marked vaccine against H7N9 subtype Avian Influenza
Speaker:
Daxin Peng
Daxin Peng
China
15:54hs
9/19/2019
Silk Room 2-4
16:18hs
9/19/2019
Silk Room 2-4
Charting H9N2 Avian influenza virus by antigenic cartography for efficacious vaccine candidate selection
Speaker:
I Wayan Wisaksana Yasa
I Wayan Wisaksana Yasa
16:18hs
9/19/2019
Silk Room 2-4
16:18hs
9/19/2019
Nile Room 1-2
Induction of clinical protection and reduction of shedding after vaccination with the first dual construct rHVT-ND-IBD against a ND genotype VII challenge
Speaker:
Rik.koopman
Rik.koopman
Netherlands
Veterinary Doctor
16:18hs
9/19/2019
Nile Room 1-2
16:30hs
9/19/2019
Silk Room 2-4
Amino acid mutation Q159R in the hemagglutinin of avian influenza A (H9N2) virus alters antigenicity between vaccine and field strains
Speaker:
Ruyi Gao
Ruyi Gao
16:30hs
9/19/2019
Silk Room 2-4
16:30hs
9/19/2019
Nile Room 3-4
Circulation and challenge of Turkey hemorrhagic enteritis virus are controlled by live vaccine application
Speaker:
Caterina Lupini
Caterina Lupini
Italy
16:30hs
9/19/2019
Nile Room 3-4
16:42hs
9/19/2019
Silk Room 2-4
Broad antigenic protection of chickens against H5 highly pathogenic Avian Influenza with recombinant Herpesvirus of turkey vaccine containing 2.3.4.4A Hemagglutinin insert
Speaker:
David Swayne
David Swayne
United States
Director
16:42hs
9/19/2019
Silk Room 2-4
16:54hs
9/19/2019
Nile Room 3-4
Efficacy of Different Vaccination Programs of Recombinant HVT-NDV Vaccines Against Newcastle Disease Virus Challenge in Broiler Chickens
Speaker:
Nataya Charoenvisal
Nataya Charoenvisal
Thailand
16:54hs
9/19/2019
Nile Room 3-4
16:54hs
9/19/2019
Amber Room 1-3
Evaluation of the efficacy of a modified live escherichia coli vaccine in commercial laying hens against field challenges at 23 or 44 weeks of age
Speaker:
Choew Kong Mah
Choew Kong Mah
16:54hs
9/19/2019
Amber Room 1-3
16:54hs
9/19/2019
Silk Room 2-4
Protection afforded by a trivalent inactivated Avian Influenza H5N1/H5N8 vaccine against highly pathogenic H5N1 and H5N8 challenge in chickens
Speaker:
Walid Hamdy Kilany
Walid Hamdy Kilany
16:54hs
9/19/2019
Silk Room 2-4
16:54hs
9/19/2019
Bhiraj Hall 2-3
Verification of in ovo vaccination using nextgeneration sequencing and a traffic light-style scoring system
Speaker:
Elise Myers
Elise Myers
Canada
16:54hs
9/19/2019
Bhiraj Hall 2-3
09:00hs
9/20/2019
Bhiraj Hall 2-3
Ecosystem for promotion of innovation and commercialization of poultry vaccines
Speaker:
Datin Paduka Aini Ideris
Datin Paduka Aini Ideris
Malaysia
09:00hs
9/20/2019
Bhiraj Hall 2-3